Biofrontera Inc. BFRI
1.18
(0.02)
(1.67%)
as of 25 Sep
- Market cap
- $17.8M
- P/E
- 0.0×
Follow BFRI
Growth Flags
show if company had growth for consecutive years
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
| (988.35%) | (339.04%) | (141.30%) | (1,191.73%) |
+8 more TTM periods Free account |
|
| (28.80%) | (53.58%) | (41.59%) | (103.57%) | ||
ROIC |
(69.45%) | (155.74%) | (81.82%) | 0.00% | |
Return on Tangible Assets |
(157.82%) | (251.30%) | (126.24%) | (934.68%) | |
Average Days of Receivables |
43.83 | 32.77 | 63.81 | 29.41 | |
Free Cash Flow per Share |
(0.61) | (0.80) | (1.31) | (1.11) | |
Free Cash Flow |
(7.93) | (9.32) | (13.36) | (12.01) | |
Capital Expenditures |
0.00 | 0.00 | 0.00 | 0.00 | |
Piotroski F-Score |
5.00 | 5.00 | 4.00 | 3.00 | |
| Other line items | |||||
Cash ROIC |
(52.00%) | (54.42%) | (62.23%) | (226.11%) | |
Accounts Receivable Turnover |
9.72 | 10.92 | 6.62 | 9.45 | |
Accounts Payable Turnover |
1.86 | 1.80 | 1.58 | 2.32 | |
Inventory Turnover |
3.74 | 2.53 | 2.72 | 2.44 | |
Average Days of Payables |
204.18 | 184.10 | 221.92 | 157.10 | |
Days of Inventory on Hand |
41.80 | 45.79 | 47.47 | 119.46 | |
Tax Rate |
0.01 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
6.48% | 7.90% | 8.92% | 9.99% | |
Selling, General and Administrative Expense of Revenue |
86.15% | 94.22% | 92.00% | 101.82% | |
Share Based Compensation of Revenue |
2.45% | 2.44% | 2.28% | 2.59% | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
1.25 | 0.84 | 1.27 | 0.68 | |
Depreciation/Fixed assets |
0.38 | 0.38 | 0.40 | 43.45 | |
Capex/Depreciation |
0.00 | 0.00 | 0.00 | 0.00 | |
Revenue per Share |
3.57 | 3.70 | 4.10 | 3.45 | |
Operating CF per Share |
(0.61) | (0.80) | (1.31) | (1.11) | |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 | |
Net Profit Margin |
(13.78%) | (25.66%) | (25.26%) | (47.28%) |
Columns are period end dates